PMC:7381711 / 17228-17432 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T151","span":{"begin":86,"end":93},"obj":"Body_part"},{"id":"T152","span":{"begin":94,"end":102},"obj":"Body_part"}],"attributes":[{"id":"A151","pred":"fma_id","subj":"T151","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A152","pred":"fma_id","subj":"T152","obj":"http://purl.org/sig/ont/fma/fma62851"}],"text":"This feared adverse effect is driven by the development of antibodies specific to the protein platelet factor 4, which leads to life-threatening thrombocytopenia and paradoxical development of thrombosis."}

{"project":"LitCovid-PubTator","denotations":[{"id":"610","span":{"begin":145,"end":161},"obj":"Disease"},{"id":"611","span":{"begin":193,"end":203},"obj":"Disease"}],"attributes":[{"id":"A610","pred":"tao:has_database_id","subj":"610","obj":"MESH:D013921"},{"id":"A611","pred":"tao:has_database_id","subj":"611","obj":"MESH:D013927"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"This feared adverse effect is driven by the development of antibodies specific to the protein platelet factor 4, which leads to life-threatening thrombocytopenia and paradoxical development of thrombosis."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T146","span":{"begin":145,"end":161},"obj":"Disease"},{"id":"T147","span":{"begin":193,"end":203},"obj":"Disease"}],"attributes":[{"id":"A146","pred":"mondo_id","subj":"T146","obj":"http://purl.obolibrary.org/obo/MONDO_0002049"},{"id":"A147","pred":"mondo_id","subj":"T147","obj":"http://purl.obolibrary.org/obo/MONDO_0000831"}],"text":"This feared adverse effect is driven by the development of antibodies specific to the protein platelet factor 4, which leads to life-threatening thrombocytopenia and paradoxical development of thrombosis."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T201","span":{"begin":86,"end":93},"obj":"Chemical"}],"attributes":[{"id":"A201","pred":"chebi_id","subj":"T201","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"This feared adverse effect is driven by the development of antibodies specific to the protein platelet factor 4, which leads to life-threatening thrombocytopenia and paradoxical development of thrombosis."}

{"project":"LitCovid-sentences","denotations":[{"id":"T105","span":{"begin":0,"end":204},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"This feared adverse effect is driven by the development of antibodies specific to the protein platelet factor 4, which leads to life-threatening thrombocytopenia and paradoxical development of thrombosis."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T40","span":{"begin":145,"end":161},"obj":"Phenotype"}],"attributes":[{"id":"A40","pred":"hp_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/HP_0001873"}],"text":"This feared adverse effect is driven by the development of antibodies specific to the protein platelet factor 4, which leads to life-threatening thrombocytopenia and paradoxical development of thrombosis."}